National Cancer Institute
National Cancer Institute U.S. National Institutes of Health

IOM Recommendations – NCI Clinical Trials Cooperative Group Program

As NCI begins to respond to the IOM recommendations and other stakeholders' input regarding streamlining the Cooperative Groups, the following resources are available:

Presentation to the Board of Scientific Advisors View slides of NCI's 11/7/11 presentation to the Board of Scientific Advisors outlining the proposed plan for transforming the Cooperative Group system with a new Request for Application (RFA).

Presentation to the Cooperative Group ChairsView slides of NCI's initial 11/29/10 presentation on transforming the Clinical Trials Cooperative Group Program, which focused on the recommendations regarding consolidation of the adult Cooperative Groups and on integration of the entire Program.

NCI's Progress on IOM Goals and RecommendationsReview the changes and improvements in efficiency that NCI has put in place over the past five years.

Backgrounder and FAQsRead about NCI's Cooperative Group Program and the Institute's efforts to transform the clinical trials enterprise, and view the most frequently asked questions about changes in the Cooperative Group Program.